Tianjin Pharma Group Proposes Shareholder-Approved Amendments

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced proposed amendments to an existing non-compete undertaking by its controlling shareholder, Tianjin Pharmaceutical Holdings Co., Ltd. The board has approved these amendments, which are aimed at transferring control of certain subsidiaries, pending shareholders’ approval. This move is part of the company’s strategy to bolster its growth and adhere to regulatory guidelines.

For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.